Breathlessness Clinical Trial
Official title:
Effects of Inhaled Furosemide on Breathlessness During Exercise in the Presence of External Thoracic Restriction: A Dose-Reponse Study
Breathlessness on exertion is a common and troublesome complaint of individuals with restrictive lung disorders. In these adults, breathlessness contributes to physical activity-limitation and avoidance and an adverse health-related quality-of-life, often in a self-perpetuating cycle. It follows that alleviating dyspnea and improving exercise tolerance are among the principal goals in the management of adults with restrictive lung disorders. Nevertheless, effective management of breathlessness and physical activity-limitation remains an elusive goal for many healthcare providers and current therapies (e.g., antifibrotic agents, oxygen, exercise training) are only partially successful in this regard. Thus, research aimed at identifying breathlessness-specific medications to complement existing therapies for the management of physical activity-related breathlessness in restrictive lung disorders is timely and both clinically and physiologically relevant. The purpose of this randomized crossover study study is to examine the acute effects of two doses of inhaled nebulized furosemide (a loop diuretic) on the perception of breathlessness during laboratory-based cycle exercise in healthy, young men in the presence of an external thoracic restriction to mimic a 'mild' restrictive lung deficit. To this end, the investigators will compare the effects of inhaled 0.9% saline placebo and inhaled furosemide (40 mg and 120 mg) on detailed assessments of breathlessness (sensory intensity and affective responses) and its physiological determinants (ventilation, breathing pattern, dynamic operating lung volumes, cardio-metabolic function) symptom-limited, high-intensity, constant-work-rate cycle exercise testing with external thoracic restriction sufficient to mimic a 'mild' restrictive pulmonary deficit in healthy, men aged 18-40 years.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03604822 -
Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS
|
N/A | |
Completed |
NCT03222648 -
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis
|
N/A | |
Completed |
NCT04739488 -
Breathibg Exercises and Inhaler Trainingfor Chronic Obstructive Pulmonary Disease (COPD) Patients
|
N/A | |
Completed |
NCT01399541 -
Recovery and Rehabilitation After Lung Cancer Surgery
|
||
Completed |
NCT01585883 -
Self-Management Intervention for Breathlessness in Lung Cancer
|
N/A | |
Enrolling by invitation |
NCT05625854 -
Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness
|
N/A | |
Completed |
NCT05430503 -
Long COVID and Post-exertional Pulmonary Diffusion
|
||
Completed |
NCT03137524 -
Fan Therapy in COPD Patients
|
N/A | |
Completed |
NCT03468205 -
The Relating Experienced To Recalled Breathlessness Observational Study
|
||
Active, not recruiting |
NCT05984186 -
Wingate-type Exercise Test to Evaluate the Effect of High Velocity Therapy on Recovery Sensation and Blood Lactate Decline
|
||
Withdrawn |
NCT05304494 -
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
|
||
Completed |
NCT02622412 -
Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease
|
N/A | |
Completed |
NCT03458182 -
Breathlessness During Exercise: Experience and Memory
|
N/A | |
Not yet recruiting |
NCT03060993 -
CAN BREATHE in COPD Trial
|
Phase 2 | |
Withdrawn |
NCT03653104 -
Melodica Orchestra for Dyspnea: Safety and Feasibility Pilot
|
N/A | |
Completed |
NCT01937637 -
Improving Management of Breathlessness in Patients With Lung Cancer
|
N/A | |
Completed |
NCT03096509 -
Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes
|
||
Completed |
NCT04630743 -
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease
|
N/A | |
Completed |
NCT03672994 -
Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient
|
||
Not yet recruiting |
NCT01738711 -
Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients
|
N/A |